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ABSTRACT  We  surveyed published  reports on  about  50 glycoproteins  whose  amino  acid 
sequence, glycosylation sites, and type of glycosylation at a particular site have been estab- 
lished. We note that high-mannose substances were rarely found at the N-terminal side of a 
previously glycosylated complex site. There was a very definite distribution  of complex sites 
about  the  N-terminal  region. Furthermore,  secreted glycoproteins  usually contained  only 
complex oligosaccharides whereas membrane proteins contained both types. We suggest that 
the  position  of the glycosylation  site with  respect to the N-terminus  affects the extent  of 
oligosaccharide processing and subsequent presentation of complex or high-mannose struc- 
tures in the mature glycoprotein.  This review relates glycosylation type to its position  in the 
known  sequence  of  given proteins  and  discusses these observations  in  light  of  known 
glycosylation processing reactions. 
Although the pathways and reactions leading to the formation 
of asparagine-linked  carbohydrates have been  described in 
detail (71),  regulation of the expression of a particular form 
of glycosylation at the cell surface or in other mature forms 
such  as  viruses  is  not  understood.  Regulatory effects are 
apparent in the glycoproteins of Sindbis,  vesicular stomatitis, 
and influenza virus because exact structure depends upon the 
type of host  cell  (24,  39,  109). It  was  also  found that  in 
ovalbumin purified from different individual hens there were 
differences in the proportions of the five major glycopeptide 
classes characteristic of ovalbumin. These proportions were 
constant in a series of eggs from the same individual but were 
different between individuals (75). These differences may be 
partially  explained  by  observations that  the  structure  and 
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(e.g., in thyroglobulin M9GIcNAc:Asn). 
conformation of the protein backbone are important in the 
final expressed form of oligosaccharide (109,  134, 169). It is 
also significant that Sindbis virus glycoproteins E 1 and E2 are 
translated in the same intracellular compartment from a single 
26S mRNA (31), yet they exhibit distinctly different forms of 
glycosylation (60), presumably because of differences in pro- 
tein  folding.  In  addition,  physiological status  may play an 
important role because the frequency of occurrence of partic- 
ular oligosaccharide structures is seen to be growth dependent. 
This is  illustrated  by density-inhibited cells,  which  process 
oligosaccharides more completely (1),  possibly a  result of a 
novel a-mannosidase that appears in confluent cells (173). 
The two major classes ofasparagine-linked oligosaccharides 
are the high-mannose and complex types: ~ 
High-Mannose 
~c~1,6 
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/cd,3  a 1,2  Man 
GicNAc  /31,4 GIcNAc fl  Asn 
Abbreviations used in this paper. Man, mannose; GIcNAc, N-ace- 
tylglucosamine; NANA, N-acetylneuraminic  acid; and Gal, galactose. 
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(e.g~, in Sindbis virus). 
There are a large number of different high-mannose oligo- 
saccharides that in mature form contain four or more man- 
nose groups, in various polymers, linked to dichitobiose. Their 
synthetic precursors, in animal cells and yeast, contain three 
glucose and nine mannose residues. In animal cells, the final 
products of these polymers have no more than nine mannoses, 
but in yeast they may be much larger (168).  Complex oligo- 
saccharides  contain  various  numbers  of other  sugars,  i.e., 
fucose, N-acetylglucosamine, galactose, and sialic acid linked 
to a core of three mannoses, including a # 1,4 linked mannose, 
3-0-  and 6-0-substituted with a-mannose, and dichitobiose. 
Complex types also  contain  varying numbers  of branched 
arms termed bi-, tri-, or tetra-antennary, where substitutions 
with #-GlcNAc occur on the  a(l,3)- or a(l,6)-linked  man- 
noses of the core. Hybrid structures (25) also exist,  e.g., that 
of rhodopsin glycopeptide (50; for review see reference 105): 
Man\a 1,6 
Man 
GlcNAc  #1'2  Man/°d'3 
Thus some oligosaccharides can be of the high-mannose type 
with respect to composition but are actually completely proc- 
essed by mannosidases as are complex-type molecules. Fur- 
ther  processing  to  complex  substances  does  not  occur.  It 
follows that because these glycosyltransferases act posttransla- 
tionally, there must be some additional structural aspect of a 
protein that specifies its oligosaccharide. In this regard, it has 
been suggested (7,  108, 134,  163) that the local environment 
surrounding the asparagine determines the accessibility of the 
processing enzymes and therefore the final form of the oligo- 
saccharides. 
Delineation of glycoprotein amino acid sequence and oli- 
gosaccharide  structure  has  facilitated  increasingly  detailed 
correlations between protein primary and secondary structure 
and glycosylation. Sites of N-linked carbohydrate attachment 
can be predicted because the sequence Asn-X-Ser(Thr) has 
been shown to be a necessary but not sufficient condition for 
glycosylation (40,  73,  97,  112, 113, 147). Such  a  sequence, 
however, does not always result in glycosylation (e.g.,  oval- 
bumin  [70,  100]);  thus other factors must apply.  More re- 
cently, reverse B-turns have been correlated with glycosylation 
of this tripeptide (2-4,  14,  107). There is currently no defini- 
tive  explanation  as  to  the  regulation  of expression  of the 
numerous asparagine-linked oligosaccharide  structures that 
have been reported. 
In this paper, we review the available information on oli- 
gosaccharide type, i.e., complex or high-mannose, with regard 
to  its  position  in  the  amino  acid  chain.  We  note  that,  in 
general,  complex  oligosaccharides  are  located  towards  the 
amino terminus of the  polypeptide and that  high-mannose 
types are located farther towards the carboxyl terminus. Proc- 
essing (see reference 71 for review) is more complete towards 
the N-terminus. We also note that serum glycoproteins usually 
contain complex structures only and that membrane glyco- 
proteins contain both types. 
GENERAL  OBSERVATIONS 
Fig.  1 depicts the results of a  literature search in which the 
type of glycosylation was compared with the location of the 
glycosylation site. Generally, complex oligosaccharides appear 
near amino termini and high-mannose structures are farther 
downstream towards carboxyl termini. The 105 complex sites 
are located at a mean amino acid site 109.1 ___ 115.2 (standard 
deviation [SD]) residues from the amino terminus and the 24 
high-mannose sites are located at a mean residue 224 ___ 174.4 
(SD)  amino  acids  from the  N-terminus.  These  means  are 
significantly different in the Student's t test (P <  0.01). The 
#1,4  GIcNAc #1,4  GlcNAc  #  Asn 
different distributions  of complex and high-mannose struc- 
tures on glycoproteins in general are clearly seen in Fig. 2, in 
which the percentages of the two oligosaccharide types falling 
within  100 amino acids of the amino terminus, between 100 
and 199 amino acids, and greater than 199 amino acids from 
the N-terminus are graphed. The ratio of the percentage of 
high-mannose to complex oligosaccharides at 100-199 amino 
acids from the N-terminus (0.66 or 12.5%  -  19%) is higher 
than at sites within  100 amino acids from it (0.51  or 33.3% 
--: 65.7%). This ratio is much higher at sites farther than 199 
amino acids from the N-terminus (3.56 or 54.2%  -  15.2%), 
i.e., the farther an attachment site is from the amino terminus, 
the greater the likelihood that it will contain a high-mannose 
structure. 
Of the  54 glycoproteins represented in  Figs.  1 and 2,  15 
contain  both  complex  and  high-mannose  oligosaccharide 
types.  This  subset  of glycoproteins  shows  an  asymmetric 
distribution  of oligosaccharides (Fig.  3)  which  is similar to 
that  of glycoproteins in  general  (Fig.  2).  In  12  of the  15 
glycoproteins that  contain  both  oligosaccharide  types,  the 
complex oligosaccharide is on the amino terminal side of the 
oligomannosyl structure.  This  80%  fit is  significant  in  the 
Chi-squared test (P <  0.05). 
Membrane GIycoproteins 
Membrane  glycoproteins  often  contained  both  complex 
and high-mannose glycosylation sites (Fig.  1, Table I) and, in 
general, the latter were located with a greater frequency toward 
the C-terminus. Semliki Forest virus precursor P62  is post- 
translationally cleaved to E2 and E3 (30,  146). E3, the amino 
terminal portion  of the polypeptide, contains one complex 
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FIGURE  1  Glycosylation  form and position in sequence. Each num- 
ber represents an individual glycoprotein and corresponds  to the 
same number in Table I (wherein the sequence and glycosylation 
parameters of the glycoprotein are described).  The length of the 
line next to each number represents the number of amino acids in 
the glycoprotein. Each plus (+) represents the location of a complex 
oligosaccharide  on the glycoprotein and each circle (O) represents 
an high-mannose structure.  Parentheses surrounding on oligosac- 
charide indicate that the location of the glycosylation  site(s) is within 
the parentheses but has not been precisely determined. 
oligosaccharide  (48,  98,  119). Its  carboxyl  portion,  which 
forms E2, has two glycosylation sites and contains predomi- 
nantly high-mannose oligosaccharides (48,  98,  119). Sindbis 
virus E3 also contains the complex forms (60).  Sindbis virus 
E2 has a complex oligosaccharide at amino acid number 196 
and a high-mannose oligosaccharide at 358 (24).  Sindbis El 
has a complex structure at 138 and a high-mannose structure 
"~  7O 
._  40 
60 
8  5O 
o 
50 
20, 
~o 
#_ 
7~ 
// 
/I 
// 
// 
// 
// 
ft 
!1 
1-99 
Complex [n =  105) 
('--I High Monn0se(n  =24) 
I00-199  -> 200 
Number of Amino Acids From The  N-terminus 
FIGURE 2  Location of complex and  high-mannose oligosaccha- 
rides  on  glycoproteins  in  general.  Complex and  high-mannose 
oligosaccharides are separately graphed according to the percent- 
ages  of their oligosaccharide attachment sites falling within  100 
amino acids of their amino termini, between 100 and 199 amino 
acids, and at greater than 199 amino acids from their amino acid 
termini. Except for glycosylation sites containing hybrid oligosac- 
charides,  all  glycoproteins described  in  Fig.  1  and  Table  I  are 
included 
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FIGURE 3  Location of glycosylation sites on the subset of glyco- 
proteins containing both complex and high-mannose oligosaccha- 
rides.  Same as  Fig. 2,  except that only glycoproteins containing 
both oligosaccharide types are shown.  Includes  SbV-E3 and SFV- 
P62. 
at  244  (24).  The  membrane-bound form of mouse MOPC 
IgM contains three complex oligosaccharides at amino acids 
171,  332,  and  394,  and  a  high-mannose oligosaccharide at 
number 402  (79).  Influenza virus HA1  has six oligosaccha- 
rides  which  in  both  A/Memphis  72  (163)  and  A/Aichi/l/ 
68(X-31)  (162) are located at identical sites. Although there 
is still some doubt as to the exact structure of the oligosaccha- 
ride at amino acid 38 in X-31, in the HAl  of both strains its 
two high-mannose structures are located farther toward the 
carboxyl  terminus  than  its  four complex  oligosaccharides. 
The amino terminal two-thirds of Rauscher Murine Leuke- 
mia Virus gp70 contains only complex oligosaccharide(s) (64, 
81, 82). Since gp70 also contains high-mannose oligosaccha- 
rides, these structures must be located in its carboxyl terminus 
(81, 82). Examination of the gp70 amino acid sequence (143) 
confirms the presence of many potential glycosylation sites in 
the C-terminal part of gp70.  The Fc fragment of the heavy 
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Sequence and Glycosylation Parameters 
No.  Glycoprotein 
Amino acid number 
Complex site  Hi-man site 
Amino acids in 
polypeptide  References 
la.  Ovalbumin  239  ° 
1  b.  Ovalbumin 
2.  SFV-E2 
3a.  SFV-E1  141 
3b.  SFV-E1 
4.  SFV-E3  13, 60 
5.  SbV-E3  14 
6.  SbV-E2  196 
7.  SbV-E1  138 
8.  Glycophorin A  26 
9.  Boy. Rhodopsin  2, 14 
10.  procollagen (C-terminal) 
11.  ovomucoid  10, 53, 69, 75 
12.  IgM(Waldenstroms)  170, 332, 395 
13.  IgM(MOPC) 104E 
Soluble form  170, 332,364 
Membrane form  170, 332, 364 
14.  Influenza HA1 
Memphis  8, 22, 38, 81 
FPV  12, 28, 123,  149, 231 
Japan/305/57  11, 23, 168, 285 
A/Aichi/2/68/(x-31)  8, 22, 81, 38? 
15.  Influenza HA2 
Memphis  154 
Fowl Plague  154 
A/Japan/305/57  154 
A/Aichi/2/68/O31  154 
16.  VSVG protein  33, 178 
17.  al -acid glycoprotein  15, 38, 54, 75, 85 
18.  a-lactalbumin  45 
19.  Porcine RNAase  21, 76 
20.  Bovine RNAase 
RNAase B 
RNAase C and D  34 
RNAase A 
21.  Ovine RNAase 
RNAase A 
RNAase B 
RNAase C  34 
22.  Deoxy-RNAase 
DNAase A  18 
DNAase B 
DNAase C  18 
DNAase D 
23.  Chinchilla RNAase 
Type I 
Type 2  34 
24.  Guinea pig RNAase  21, 34 
25.  Coypu RNAase  34 
26.  Lesser Rorqual B RNAase  76 
27.  Giraffe RNAase  34 
28.  Okapi RNAase  34 
29.  Moose RNAase  34 
30.  Horse RNAase  34, 62 
31a.  Avidin  17  ° 
31b.  Avidin 
32.  Fibrinogen Y  52 
33.  HCG (alpha)  56, 82 
34.  HCG (beta)  13, 30 
35.  TSH (alpha)  56, 82 
36.  TSH (beta)  23 
37.  LH (alpha)  56, 82 
239  ° 
200, 262 
141 
358 
244 
11 
402,563 
402,563 
402 
165,285 
165,285,38? 
82 
34 
34 
34 
18 
18 
34 
17  ° 
346 
346 
422 
438 
438 
66 
64 
423 
439 
131 
360 
250 
186 
576 
576 
597 
328 
319 
324 
328 
221 
221 
222 
221 
511 
181 
123 
124 
124 
124 
124 
124 
124 
124 
257 
257 
257 
257 
124 
124 
128 
128 
? 
124 
? 
? 
124 
128 
128 
410 
96 
147 
96 
119 
96 
70,100 
70,100 
48,98,119" 
48,98,119" 
48,98,119" 
48,98,119" 
59,129 
24 
23 
155,166 
45,61 
118,144 
14 
125,141 
79,80 
79, 80 
163 
123,84 
51,109,164 
160,162 
163 
123,84 
51,109,164 
160,162 
39,133 
44,137,138,167 
22,68 
76,77 
67,122 
67,121 
67,121 
13,85 
13,85 
13,85 
91,135 
91, 135 
91,135 
90,91,135 
15 
15 
15 
15 
15,38 
47 
15 
15 
136~ 
36,69 
36,69 
65,156 
120 
120 
120 
120 
120 
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Sequence and Glycosylation Parameters 
Amino acid number 
Amino acids in 
No.  Glycoprotein  Complex site  Hi-man site  polypeptide  References 
38.  LH (beta) 
porcine, ovine, bovine  13  121  120 
human  13  116  120 
39.  FSH (alpha)  56, 81  96  120 
40.  FSH (beta)  7, 24  120  120 
41.  Bence Jones SM-light chain)  25  135  26, 49 
42.  Bence Jones NEl-light-chain  93  214  50 
43.  Bence Jones Wh-V region  94  107  83 
44.  IgG  297  446  37, 87 
45.  HLA-B7  86  336  116, 117 
46.  H2-K b  86, 176  346  32, 111 
47.  Interferon (IFN-B)  80  166  20,  151 
48.  IgE(Heavy chain)  145, 173,219, 265, 371  394  547  18 
49.  Human transferrin  414, 608  676  58, 103 
50.  MOPC-46K-Kappa  28  ~240  101, 102 
51.  Myelin P O  protein  14  ~280  74 
52.  MOPC 47A  155  330  131 
53.  IgD (mouse, membrane-bound)  In N-terminal  C-terminal  ~460  56 
two thirds  third 
54.  IgD Fc fragment (human solu-  159, 210  68  226  142, 92:[: 
ble, C-ter.) 
55.  MuLV gp70  45, possibly others in C-ter.  In C-ter. only  64, 81, 82,  143 
56.  bovine prothrombin  77, 101,376  582  96,  104 
Results of a literature search in which the type of glycosylation was compared with the location of the glycosylation site. The number of amino acids from the 
N-terminus  of each complex or high-mannose asparagine-linked oligosaccharide is listed for each polypeptide. Proteins for which only partial information was 
available, i.e., amino acid sequence data or carbohydrate analysis alone, are not shown. 
* Denotes Atkinson et al., unpublished observations. 
:1: Denotes Scott Mellis and Jaques Baenziger, personal communication; and o denotes a hybrid structure. 
chain of murine cell surface IgD binds only partially to lentil 
lectin but binds completely to concanavalin A.  In contrast, 
the Fab and Fab' fragments bind completely to both columns 
(56). The binding specificity of  these lectins (86,  110) indicates 
that complex biantennary oligosaccharides are located in the 
Fab  and  Fab'  fragments (amino  terminus)  and  that  high- 
mannose oligosaccharides are in the Fc portion (C-terminus). 
The only exception observed for a  membrane protein  is 
Fowl Plague virus HA2. It has a high-mannose oligosaccharide 
at amino acid 82 and a complex oligosaccharide at 154 (84). 
In some cases, HA is apparently not cleaved intracellularly. 
Cleavage is dependent  on  the  host  cell  and  is also  strain- 
dependent (19,  ! 50). When uncleaved HA is cleaved in vitro 
with trypsin, the HA 1  s in some strains contain both oligosac- 
charide types and the corresponding HA2s contain complex 
oligosaccharides (109,  139). Since HA1  contains the amino 
terminus of HA and since HA2 contains HAs carboxyl ter- 
minus, this is seemingly an exception to the general order of 
appearance of high-mannose and complex oligosaccharides. 
However, it is difficult to electrophoretically separate in vivo 
cleaved HA1  and HA2, even in the presence of SDS and a 
reducing agent (63).  Although cleavage in vivo was not de- 
tected  (109,  139),  it  is  not  certain  that  the  electrophoretic 
conditions used in these studies would separate in vivo cleaved 
HA l from HA2. It is therefore possible that at least some HA 
had been cleaved prior to the in vitro trypsinization. None- 
theless,  the structure of HA2 has been demonstrated to affect 
the  extent  of processing  on  HAl  in  A/Udorn/72  (H3N2): 
deletions were introduced near the carboxyl terminus of HA2 
and the mutant HA was expressed using an simian virus 40- 
HA construct.  Whereas the  wild-type HA contained  high- 
mannose oligosaccharides, the  mutant  (169),  which  would 
normally be located in HA 1 of the H3N2 serotype (139),  did 
not. The env protein (G2) of Rous Sarcoma virus has both 
complex and high-mannose oligosaccharides in a ratio of 3:1 
and probably has ten complex and three high-mannose struc- 
tures (88),  though the sequence distribution of its glycosyla- 
tion sites is not known. Likewise, HA of Influenza virus A/ 
USSR has three complex and two high-mannose tryptic pep- 
tides  of known  composition  (l 1)  though  position  in  the 
sequence (33) is not known. Fitting the peptides to the appro- 
priate sites, as was done with Sindbis virus (129), would seem 
an elegant way in which to obtain this information for these 
cases and in general. 
Soluble  Glycoproteins 
Most glycoproteins found in serum contain only complex 
oligosaccharides (Table I). In ovomucoid, a-l acid glycopro- 
tein, c~-lactalbumin,  avidin (which probably has a rhodopsin- 
like structure based on its sugar composition [69]), fibrinogen, 
human  chorionic  gonadotropin,  thyroid-stimulating  hor- 
mone,  porcine  luteinizing  hormone,  interferon,  ceruloplas- 
rain,  the PO protein from myelin, a-1  microglobulin, inter 
alia, one or more complex oligosaccharides are located within 
100  amino acids of the amino terminus (Table I). Human 
transferrin  is  an  exception,  having  complex  structures  at 
amino acids 414 and 608, as is prothrombin (96,  104) which 
contains complex structures at amino acids 77,  101, and 376. 
Bovine lactotransferrin, however, contains high-mannose ol- 
igosaccharides, although  their locations in  the glycoprotein 
are not known (159). 
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oligosaccharides. The oligosaccharide ofprocollagen is located 
at residue  180  of its  250  amino  acid  carboxyl propeptide. 
Ovalbumin's oligosaccharide is at amino acid 239. These high- 
mannose sites are located markedly farther from the N-ter- 
minus than the glycosylation sites of most soluble glycopro- 
reins. 
The soluble forms of the epsilon, mu, and delta immuno- 
globulin chains contain both complex and simple carbohy- 
drates. The epsilon chain contains five complex and one high- 
mannose oligosaccharide per chain (6, 7). Of these, the high- 
mannose structure is closest to its carboxyl terminus (18). The 
soluble  chains  of both  human  (Waldenstrom)  and  mouse 
(MOPC  104E)  IgM  have a  similar arrangement;  i.e.,  three 
complex oligosaccharides towards the  amino terminus and 
two  high-mannose  structures  farther  towards  the  carboxyl 
terminus.  It is remarkable that the  site at  563  on  the  572 
amino  acid  IgM  heavy chain  is glycosylated at  all  since  a 
minimum  of  30  amino  acids  must  be  added  beyond  an 
acceptor site for glycosylation to occur during translation (54). 
Soluble  forms  of gamma  and  alpha  chains  contain  only 
complex oligosaccharides (6-8,  93,  95).  However,  Dawson 
and Clamp (34) concluded that a glycopeptide from an IgA 
myeloma contained only mannose and glucosamine and was 
contaminated with galactose and fucose. Low et al. (95) found 
that the oligosaccharide of IgA closest to its carboxyl terminus 
has a sugar composition similar to that of the glycopeptide 
studied by Dawson and Clamp (34).  Its mannose to glucosa- 
mine ratio (1.58:1)  is considerably higher than those of two 
other N-linked oligosaccharides in IgA (0.69:1  and 0.79:1).  It 
is therefore possible that this substance is actually high-man- 
nose or hybrid type. 
The  Fc  fragment of soluble  human  IgD delta  chain  has 
three glycosylation sites (92,  142). It is an exception to the 
usual  locations of high-mannose and  complex oligosaccha- 
rides since the site at residue 68 is high-mannose and those at 
159 and 210 are complex. Furthermore, the glycosylation of 
the high-mannose site is unusual because ~20% of its oligo- 
saccharides are glucosylated (Scott Mellis and Jaques Baen- 
ziger,  personal communications). IgD is also exceptional in 
that the two primary translation products of the human delta 
chain (which correspond to membrane and secreted forms of 
IgD) are differentially N-glycosylated to four discrete forms 
(99).  There  is  evidence  that  glycosylation protects  against 
proteolysis (27-29, 42, 161). The exquisite protease sensitivity 
of IgD (148) shows an inability of glycosylation to exert this 
effect. It is also notable that although secretion of murine IgM 
and IgE is inhibited  by tunicamycin, that of IgD and IgG, 
which is glycosylated at only one site, is not inhibited (145). 
Pancreatic ribonucleases and deoxyribonucleases are excep- 
tions to the glycosylation patterns usually observed for soluble 
glycoproteins. They can have high-mannose structures near 
their amino termini and they can also have a complex oligo- 
saccharide  following a  high-mannose.  Porcine ribonuclease 
has a high-mannose oligosaccharide at amino acid 34 and this 
is  followed  at  number  76  by  a  complex  oligosaccharide. 
Ribonucleases from other species are generally.glycosylated 
at amino acid 34 only, although horse ribonuclease has com- 
plex oligosaccharides at 21, 34, and 62, guinea pig at 21  and 
34, and lesser rorqual at 76 only (15). The oligosaccharide at 
34 may be complex (giraffe, okapi, moose, and coypu), either 
complex or high-mannose (chinchilla,  sheep,  and  cow),  or 
can  occur  with  or without  the  oligosaccharide  (topi,  cow, 
sheep, goat, and  roe deer).  Deoxyribonuclease is similar; it 
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also exhibits either high-mannose or complex otigosaccharides 
at its single glycosylation site, amino acid  18 (90).  It may be 
difficult for such short molecules to achieve sufficient folding 
for processing to be interfered with in the manner in which it 
appears to occur in many other glycoproteins. 
Although  microheterogeneity  within  an  oligosaccharide 
type is common (for review see reference 149) partial glyco- 
sylation  and  switching  between  oligosaccharide  types  at  a 
specific glycosylation site is rarer, though in  Semliki Forest 
virus E1  this does occur (P.  Atkinson, unpublished observa- 
tions). Bovine ribonuclease C and D (both glycosylated with 
complex oligosaccharides) and A (unglycosylated form) have 
half-lives in  nephrectomized  rats  of at  least  8  h,  whereas 
ribonuclease B in the high-mannose form is cleared in 15 min 
from  serum  (12)  and  it  is  possible  that  this  form  is  not 
physiologically relevant. 
DISCUSSION 
Oiigosaccharides are processed by a well defined pathway (for 
details, exceptions, and references, see reference 71).  Briefly, 
precursor  oligosaccharides  (Glc3  Man9  GlcNAc2)  are  co- 
translationally transferred to each glycosylation site from a 
lipid  intermediate.  Glucosidases,  located  in  the  rough  and 
smooth endoplasmic reticulum, rapidly alter the newly syn- 
thesized protein to form a Man9GlcNAc2 structure. Some or 
all of the four outermost mannose residues are then cleaved 
by membrane-bound mannosidases to produce the high-man- 
nose  series  of  oligosaccharides  (Mans_gGlcNAc2).  Several 
mannosidases are in or near the Golgi apparatus (126,  127, 
153); others may be in the rough endoplasmic reticulum (55). 
MansGlcNAc2 can be converted to complex oligosaccharides 
by the  addition  of a  single  GlcNAc to the  exposed "core" 
c~(1,3)-Iinked mannose residue and the subsequent rapid re- 
lease of the two terminal noncore mannose residues by the 
enzyme  "late  mannosidase"  (62).  The  trimmed  GlcNAc- 
MansGIcNAc2 structure can then be further processed by the 
addition of fucose to the innermost GlcNAc residue and by 
additions  of various  amounts  of GlcNAc,  galactose,  sialic 
acid, and fucose to the outer residues. These latter reactions 
all take place in  or near the Golgi apparatus (16,  21,  115). 
Inasmuch as there four a(l,2)-linked mannoses and two other 
c~-mannoses  are removed during processing to complex car- 
bohydrates, there are quite conceivably six different mannos- 
idases.  As an example of site specificity of c~(l,2)-mannosi- 
dase, yeast contains an a-mannosidase which will cleave one 
specific  c~-mannose  from  precursor  MangGlcNAc2,  leaving 
three  others  intact  (171).  Tabas  and  Kornfeld  (153)  and 
Tulsiani  et  al.  (157)  have  purified  several a-mannosidases 
from rat liver Golgi fractions although it is possible that there 
are other a-mannosidases in the rough endoplasmic reticu- 
lure. Forsee and Schutzbach (43) have purified an a-mannos- 
idase  from  rabbit  liver  microsomes which  has  a  substrate 
specificity similar to but a pH optimum lower than that of 
the  Golgi enzymes. Furthermore,  pulse-chase studies using 
carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of 
intracellular protein transport, suggest that an a-mannosidase 
in  the  rough  endoplasmic  reticulum  removes  one  of the 
terminal  a-mannose  residues  of  thyroglobulin  MangGlc- 
NAc2Asn (see above for its structure [55]). Our current studies 
show that nascent chain  vesicular stomatis virus-G protein 
contains oligosaccharides processed to MansGlcNAc (Atkin- 
son, manuscript in preparation). The number and exact sub- 
cellular site of c~-mannosidases  remain to be precisely eluci- 
dated.  Such  studies  may  be  complicated by the  fact that density inhibition of cell growth favors the formation of more 
processed structures (60), and that a possible induction of new 
enzymes (173), which may be an important regulatory event, 
may occur. 
Present evidence indicates that the protein primary struc- 
ture can determine whether complex or high-mannose oligo- 
saccharides will  occur (7,  109,  134,  163,  169),  and  protein 
conformation affects processing of high-mannose oligosaccha- 
ride in yeast carboxypeptidase Y and invertase (170). Carbo- 
hydrate is necessary for vesicular stomatis virus-G protein to 
attain a proper conformation (52, 53). It is also necessary in 
the stability of yeast invertase (28,  29),  carboxypeptidase Y 
(27),  alkaline  phosphatase (42),  porcine ribonuclease  (161), 
and interferon (46), for clearance of ribonuclease B (12), and 
in conformational changes which can affect the antigenicity 
of Semliki Forest virus glycoproteins (78). Since glycosylation 
does  seem  to  affect  conformation,  it  is  possible  that  the 
addition of each oligosaccharide to a nascent chain increases 
the likelihood that the next glycosylation site will mature with 
a high-mannose structure. It seems likely that the final oligo- 
saccharide  form depends  on  steric  hindrance  since  at  least 
some glycosyltransferases act after folding of the protein has 
taken  place  (2).  Indeed,  x-ray  crystallographic  analysis  of 
influenza HA (165) shows that, although both types of oligo- 
saccharide are either at or near Ha's surface, the glycosylation 
sites  of the  complex  oligosaccharides  appear  to  be  more 
exposed than those of  the high-mannose structures. A physical 
explanation  of why processing occurs more towards the N- 
terminus may be that the amino terminal sites are translated 
first  or because the  C-terminal  sites  are often closer to the 
membrane (94), where the C-terminal is buried. 
The function ofglycoprotein N-linked oligosaccharides and 
their asymmetric distributions  remains to be demonstrated. 
The tissue specificity of the asiaioglycoprotein receptor (12, 
35,  106,  132) indicates that complex-type glycopeptides may 
be  important  in  targeting  these  glycoproteins to  a  specific 
tissue.  The  exact  fine  structure  in  this  type  of recognition 
mediated by complex carbohydrates is also important because 
Baenziger and Fiete (5) have shown that triantennary complex 
oligosaccharides  with  three  terminal  galactose  residues  are 
endocytosed by rat hepatocytes, whereas biantennary complex 
oligosaccharides with one or two terminal galactose residues 
are not endocytosed. In other manifestations of the effect of 
glycosylation on  function,  inhibition  of glycosylation of a 
polyprotein precursor inhibits its cleavage (172). Cleavage of 
such a  polyprotein would also cause the glycosylation site(s) 
of its  C-terminal  polypeptide(s)  to  be  closer to  the  amino 
terminus  of the  cleaved  product.  The  time  of cleavage  of 
cotranslated proteins and their form of glycosylation prior to 
this  cleavage (59)  are  important  parameters  to  consider  in 
these cases. High-mannose structures have been demonstrated 
as significant if not major components of N-linked oligosac- 
charides exposed on the surfaces of many cell types (Ceccarini 
and P. H. Atkinson, unpublished observations) as have com- 
plex  structures  (reviewed  in  1).  How the  various  forms  of 
these types of oligosaccharides appear on the cell surface is 
not  directly  known,  but  they  are  involved  in  recognition 
functions in specific adhesion of cells (57,  128,  130)  and  in 
development  (152).  Aside  from  their  involvement  in  cell 
surface  recognition,  high-mannose  oligosaccharides  are  in- 
volved in directing lysosomal enzymes to their correct sub- 
cellular compartment (for review, see reference i 14). 
The functional significance, if any, of the different distri- 
butions  of complex  and  high-mannose  oligosaccharides  on 
their protein backbones is not known. However, if, as current 
sequence and glycosylation data indicate, asymmetric distri- 
butions of oligosaccharide types occur, we believe that this 
could be a significant determinant as to how oligosaccharides 
participate in recognition events. 
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Notes Added  in Proof  The complete  amino acid sequence  of the 
heavy chain of human IgD has recently been determined  by Taka- 
hashi, N., D. Tetatert,  B. Debuiere,  L.-C. Lin, and S. W. Putnam, 
(Proc. Natl. Acad. Sci. USA. 79:2850-2854,  1982). 
Since the manuscript  was submitted,  we have completed  a study 
using 500 MHz ~H-nuclear magnetic resonance (NMR) spectroscopy 
on the oligosaccharides of MOPC 104E IgM (Anderson, D, R., P. H. 
Atkinson,  and W. J. Grimes,  Major carbohydrate  structures  at five 
glycosylation sites on murine IgM determined  by high resolution ~H- 
NMR spectroscopy, manuscript in preparation). We found a bianten- 
nary structure  at position  171, triantennary  structures, two arms of 
which  terminated  in  galactose,  at  positions  332  and  364, a  less 
processed triantennary  structure terminating  in GIcNAc at position 
403, and a high-mannose structure at position 563. 
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